Paul Grint

Paul Grint is an accomplished executive with extensive experience in the biotechnology and pharmaceutical sectors. Currently serving as Executive Chairman at Codagenix Inc. and a Board Member for multiple organizations including CRISPR QC and Persephone Biosciences, Paul Grint also fulfills the role of Entrepreneur In Residence at the University of California San Diego. Past leadership positions include CEO of AmpliPhi Biosciences and President & CEO of Regulus Therapeutics, along with significant roles at Cerexa and Forest Laboratories. Paul Grint holds a Bachelor of Medicine, Bachelor of Surgery (MBBS) from St. Bartholomew's Hospital, University of London, and attended Stowe School.